Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Berthold

Showing results (11-20 of 162) with videos related to

Pageof 17
Sort By:
Current Pharmaceutical Design|January 16, 2013
The role of niacin in lipid-lowering treatment: are we aiming too high?Ioanna Gouni-Berthold, Heiner K Berthold
Atherosclerosis. Supplements|May 5, 2015
Mipomersen and lomitapide: Two new drugs for the treatment of homozygous familial hypercholesterolemiaIoanna Gouni-Berthold, Heiner K Berthold
Handbook of Experimental Pharmacology|October 3, 2012
Role of physician gender in drug therapyI Gouni-Berthold, H K Berthold
Current Pharmaceutical Design|December 11, 2013
Pharmacologic therapy for cardiovascular risk reduction in patients with the metabolic syndromeIoanna Gouni-Berthold, Heiner K Berthold
Der Internist|November 19, 2009
[Drug therapy in the elderly :what are the problems? What are the dos and don'ts?]H K Berthold, E Steinhagen-Thiessen
Current Pharmaceutical Design|June 24, 2014
Familial hypercholesterolemia: etiology, diagnosis and new treatment optionsIoanna Gouni-Berthold, Heiner K Berthold
Current Vascular Pharmacology|March 19, 2020
Vitamin D and Vascular DiseaseIoanna Gouni-Berthold, Heiner K Berthold
Current Pharmaceutical Design|March 23, 2011
Lipid-lowering drug therapy in elderly patientsHeiner K Berthold, Ioanna Gouni-Berthold
Current Pharmaceutical Design|November 15, 2011
Role of physician gender in the quality of care of cardiometabolic diseasesI Gouni-Berthold, H K Berthold
American Heart Journal|February 9, 2002
Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agentIoanna Gouni-Berthold, Heiner K Berthold
Pageof 17

Showing results (11-20 of 162) with videos related to

Sort By:
Pageof 17
Current Pharmaceutical Design|January 16, 2013
The role of niacin in lipid-lowering treatment: are we aiming too high?Ioanna Gouni-Berthold, Heiner K Berthold
Atherosclerosis. Supplements|May 5, 2015
Mipomersen and lomitapide: Two new drugs for the treatment of homozygous familial hypercholesterolemiaIoanna Gouni-Berthold, Heiner K Berthold
Handbook of Experimental Pharmacology|October 3, 2012
Role of physician gender in drug therapyI Gouni-Berthold, H K Berthold
Current Pharmaceutical Design|December 11, 2013
Pharmacologic therapy for cardiovascular risk reduction in patients with the metabolic syndromeIoanna Gouni-Berthold, Heiner K Berthold
Der Internist|November 19, 2009
[Drug therapy in the elderly :what are the problems? What are the dos and don'ts?]H K Berthold, E Steinhagen-Thiessen
Current Pharmaceutical Design|June 24, 2014
Familial hypercholesterolemia: etiology, diagnosis and new treatment optionsIoanna Gouni-Berthold, Heiner K Berthold
Current Vascular Pharmacology|March 19, 2020
Vitamin D and Vascular DiseaseIoanna Gouni-Berthold, Heiner K Berthold
Current Pharmaceutical Design|March 23, 2011
Lipid-lowering drug therapy in elderly patientsHeiner K Berthold, Ioanna Gouni-Berthold
Current Pharmaceutical Design|November 15, 2011
Role of physician gender in the quality of care of cardiometabolic diseasesI Gouni-Berthold, H K Berthold
American Heart Journal|February 9, 2002
Policosanol: clinical pharmacology and therapeutic significance of a new lipid-lowering agentIoanna Gouni-Berthold, Heiner K Berthold
Pageof 17